Contact
Please use this form to send email to PR contact of this press release:
Principia Presents Updated Positive Data of Rilzabrutinib for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
TO:
Please use this form to send email to PR contact of this press release:
Principia Presents Updated Positive Data of Rilzabrutinib for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
TO: